Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded…
Core Molding Technologies Reports Fiscal 2024 Third Quarter Results
COLUMBUS, Ohio, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc.…